Skip to main content
TipRanks
Go Ultimate75% OFF

Acadia Healthcare (7RA) Stock Price & Analysis

0 Followers

7RA Stock Chart & Stats

€34.20-€0.20(-0.58%)
At close: 5:30 PM GMT+1
€25€27.5€30€32.5Aug 31Sep 30Oct 7Oct 27Nov 6
Day’s Range
EUR 33.80 - EUR 34.20
52-Week Range
EUR 9.65 - EUR 35.00
Previous Close
EUR 34.40
Volume
N/A
Average Volume (3M)
31
Market Cap
EUR 3.19B
Enterprise Value
EUR 5.09B
Total Cash (Recent Filing)
EUR 163.31M
Total Debt (Recent Filing)
EUR 2.50B
Price to Earnings (P/E)
―
Beta
0.04
Next Earnings
Mar 01, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Raised Earnings Outlook

Repeated guidance increases indicate improving management confidence in the operating plan and earnings trajectory. The outlook combines higher revenue, EBITDA, adjusted EPS, and operating cash flow expectations, providing a durable foundation for execution over the next several quarters.

Capacity Expansion And Demand

New beds and facilities expand Acadia’s treatment capacity in a market where management reports strong behavioral healthcare demand. Rising acute volumes and revenue suggest the network is converting added capacity into growth, with further operating leverage possible as newer sites mature.

Improving Cash Generation

Positive free cash flow alongside debt repayment strengthens internal funding capacity and reduces reliance on external capital. If sustained, improving cash conversion can support facility investment, help manage leverage, and provide greater flexibility for strategic growth initiatives.

Bears Say

Severe Profitability Pressure

The sharp deterioration in net and gross margins indicates that revenue growth is not currently translating into comparable earnings strength. Persistent cost, pricing, or service-mix pressure could constrain reinvestment and make reported profitability volatile even as sales expand.

Elevated Leverage

Higher leverage combined with negative returns reduces financial flexibility and increases the importance of consistent cash generation. Debt obligations may limit capital allocation choices, while weak profitability makes balance-sheet improvement more dependent on operational recovery.

Ongoing Legal Investigation Costs

Material investigation-related spending remains a continuing drag on reported results and introduces uncertainty into future expenses. Even with year-over-year improvement, variable legal costs can absorb cash, complicate earnings forecasting, and distract management from operating priorities.

Acadia Healthcare News

7RA FAQ

What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was €9.65 and its highest was €35.00 in the past 12 months.
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is €3.19B.
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s next earnings report is estimated for Mar 01, 2027 (not yet confirmed), which is in 107 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Nov 04, 2026. The company reported €0.537 earnings per share for the quarter, beating the consensus estimate of €0.415 by €0.123.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is 0.35.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 92,966,680 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of €0.537 in its last earnings report, beating expectations of €0.415. Following the earnings report the stock price went up 8.219%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Hedge funds hold Acadia Healthcare shares: the largest hedge-fund position in Acadia Healthcare is 571,718,134 shares, and hedge funds increased their holdings by 545.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology